Statistics

Total Visits

Views
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer(legacy) 173
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer(legacy) 97

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer 0 4 6 1 1 1 7

File Downloads

Views

Top Country Views

Views
United States 79
Germany 62
China 17
Australia 10
Netherlands 8
Vietnam 5
France 4
Finland 2
Ireland 1
Mexico 1

Top City Views

Views
Ashburn 24
Leawood 10
Nürnberg 9
Kaleen 8
Rotterdam 8
Zhengzhou 8
Fairfield 7
Hanoi 5
San Ramon 5
Beijing 4